S, P., MI, T., CY, Y., V, S., MW, C., K, W., . . . A, M. (2024). Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. Nature communications, 15(1), 352. https://doi.org/10.1038/s41467-024-44686-5
Chicago Style (17th ed.) CitationS, Panja, et al. "Mechanism-centric Regulatory Network Identifies NME2 and MYC Programs as Markers of Enzalutamide Resistance in CRPC." Nature Communications 15, no. 1 (2024): 352. https://doi.org/10.1038/s41467-024-44686-5.
MLA (9th ed.) CitationS, Panja, et al. "Mechanism-centric Regulatory Network Identifies NME2 and MYC Programs as Markers of Enzalutamide Resistance in CRPC." Nature Communications, vol. 15, no. 1, 2024, p. 352, https://doi.org/10.1038/s41467-024-44686-5.